Unknown

Dataset Information

0

Small molecule inhibition of dipeptidyl peptidase-4 enhances bone marrow progenitor cell function and angiogenesis in diabetic wounds.


ABSTRACT: In diabetes, stromal cell-derived factor-1 (SDF-1) expression and progenitor cell recruitment are reduced. Dipeptidyl peptidase-4 (DPP-4) inhibits SDF-1 expression and progenitor cell recruitment. Here we examined the impact of the DPP-4 inhibitor, MK0626, on progenitor cell kinetics in the context of wound healing. Wildtype (WT) murine fibroblasts cultured under high-glucose to reproduce a diabetic microenvironment were exposed to MK0626, glipizide, or no treatment, and SDF-1 expression was measured with ELISA. Diabetic mice received MK0626, glipizide, or no treatment for 6 weeks and then were wounded. Immunohistochemistry was used to quantify neovascularization and SDF-1 expression. Gene expression was measured at the RNA and protein level using quantitative polymerase chain reaction and ELISA, respectively. Flow cytometry was used to characterize bone marrow-derived mesenchymal progenitor cell (BM-MPC) population recruitment to wounds. BM-MPC gene expression was assayed using microfluidic single cell analysis. WT murine fibroblasts exposed to MK0626 demonstrated increased SDF-1 expression. MK0626 treatment significantly accelerated wound healing and increased wound vascularity, SDF-1 expression, and dermal thickness in diabetic wounds. MK0626 treatment increased the number of BM-MPCs present in bone marrow and in diabetic wounds. MK0626 had no effect on BM-MPC population dynamics. BM-MPCs harvested from MK0626-treated mice exhibited increased chemotaxis in response to SDF-1 when compared to diabetic controls. Treatment with a DPP-4 inhibitor significantly improved wound healing, angiogenesis, and endogenous progenitor cell recruitment in the setting of diabetes.

SUBMITTER: Whittam AJ 

PROVIDER: S-EPMC7252504 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Small molecule inhibition of dipeptidyl peptidase-4 enhances bone marrow progenitor cell function and angiogenesis in diabetic wounds.

Whittam Alexander J AJ   Maan Zeshaan N ZN   Duscher Dominik D   Barrera Janos A JA   Hu Michael S MS   Fischer Lauren H LH   Khong Sacha S   Kwon Sun Hyung SH   Wong Victor W VW   Walmsley Graham G GG   Giacco Ferdinando F   Januszyk Michael M   Brownlee Michael M   Longaker Michael T MT   Gurtner Geoffrey C GC  

Translational research : the journal of laboratory and clinical medicine 20181102


In diabetes, stromal cell-derived factor-1 (SDF-1) expression and progenitor cell recruitment are reduced. Dipeptidyl peptidase-4 (DPP-4) inhibits SDF-1 expression and progenitor cell recruitment. Here we examined the impact of the DPP-4 inhibitor, MK0626, on progenitor cell kinetics in the context of wound healing. Wildtype (WT) murine fibroblasts cultured under high-glucose to reproduce a diabetic microenvironment were exposed to MK0626, glipizide, or no treatment, and SDF-1 expression was mea  ...[more]

Similar Datasets

| S-EPMC8907187 | biostudies-literature
2024-05-08 | GSE232178 | GEO
| S-EPMC4551869 | biostudies-literature
| S-EPMC3514763 | biostudies-literature
2011-12-31 | E-MTAB-583 | biostudies-arrayexpress
| S-EPMC8167299 | biostudies-literature
| S-EPMC6504918 | biostudies-literature
| S-EPMC7203631 | biostudies-literature
| S-EPMC8269314 | biostudies-literature
| S-EPMC2746559 | biostudies-literature